EuKedos S.p.A. (BIT: EUK)
Italy
· Delayed Price · Currency is EUR 0.810
+0.030 (3.85%)
Jan 17, 2025, 3:48 PM CET
EuKedos Revenue
EuKedos had revenue of 24.88M EUR in the half year ending June 30, 2024, with 10.61% growth. This brings the company's revenue in the last twelve months to 50.70M, up 5.22% year-over-year. In the year 2023, EuKedos had annual revenue of 49.45M with 5.12% growth.
Revenue (ttm)
50.70M
Revenue Growth
+5.22%
P/S Ratio
0.35
Revenue / Employee
104.96K
Employees
529
Market Cap
17.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 49.45M | 2.41M | 5.12% |
| Dec 31, 2022 | 47.04M | 1.86M | 4.12% |
| Dec 31, 2021 | 45.18M | -1.81M | -3.85% |
| Dec 31, 2020 | 46.99M | -6.37M | -11.94% |
| Dec 31, 2019 | 53.36M | 1.76M | 3.41% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.27B |
| Amplifon | 2.36B |
| DiaSorin | 1.18B |
| EL.En. | 665.50M |
| Philogen | 3.92M |
| Pharmanutra | 113.13M |
| Safilo Group | 1.01B |
| GPI S.p.A. | 484.01M |